Skip to content

Ironwood Pharmaceuticals

US · IRWD #3609 by market cap
4.70 -0.01 -0.21%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:01

Quant vs Street three independent views, side by side

StockVane factor grade
B-
Momentum strategy signal
Hold
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Mixed
1
■ Upgrades■ Downgrades
  • 1 upgrade vs 0 downgrades among tracked analyst rating changes.
  • Most recent: Craig-Hallum moved from Hold to Buy on 2026-01-02.

Analyst consensus 1 analysts

Buy
Avg price target 6.00 +27.7%
Price target rangecurrent 4.70
Low6.00
Avg6.00
High6.00
Buy 100% Hold 0% Sell 0%
Recent ratings (17)
DateFirmAnalystRatingTarget
2026-11-06 Craig-Hallum -- Buy 6.00
2026-07-14 Craig-Hallum -- Buy --
2026-05-13 Craig-Hallum -- Buy --
2026-05-05 Wells Fargo -- Hold 5.00
2026-03-18 Craig-Hallum -- Buy --
2026-03-11 Craig-Hallum -- Buy --
2026-02-26 Craig-Hallum -- Buy --
2026-02-26 Citizens JMP -- Buy 10.00
2026-02-23 Craig-Hallum -- Buy --
2026-01-05 Citizens JMP -- Buy 8.00
2026-01-04 Wells Fargo -- Hold 5.00
2026-01-02 Craig-Hallum -- Buy 5.70
2025-11-26 Craig-Hallum -- Hold 3.80
2025-11-11 Wells Fargo -- Hold 3.00
2025-11-10 Craig-Hallum -- Hold --
2025-11-06 Craig-Hallum -- Hold --
2025-10-29 Craig-Hallum -- Hold 1.70

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-01-02 Craig-Hallum Hold → Buy 5.70

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-05 -- -- +6.90%
2026/Q2 2026-08-06 -- ±14.73% +2.65% (in line)
2026/Q1 2026-05-07 -- ±13.46% -13.66% (beat)
2025/Q4 2026-02-25 -- ±20.65% -11.35% (in line)
2024/Q4 2025-02-27 -- -- -5.26%
2024/Q3 2024-11-07 -- ±17.16% -7.54% (in line)
2024/Q2 2024-08-08 -- ±33.78% -32.61% (in line)
2024/Q1 2024-05-09 -- ±19.46% -17.00% (in line)
2023/Q4 2024-02-15 -- ±12.91% -2.98% (in line)
2023/Q3 2023-11-09 -- ±14.83% +3.14% (in line)
2023/Q2 2023-08-08 -- ±16.64% -9.16% (in line)
2023/Q1 2023-05-04 -- ±6.66% +0.67% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 20:01:04 · For reference only, not investment advice and not tailored to your situation.

Ironwood Pharmaceuticals discussion 0 comments

Add a comment